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ABSTRACT
YvoA is a GntR/HutC transcription regulator from
Bacillus subtilis implicated in the regulation of
genes from the N-acetylglucosamine-degrading
pathway. Its 2.4-A ˚ crystal structure reveals a
homodimeric assembly with each monomer display-
ing a two-domain fold. The C-terminal domain,
which binds the effector N-acetylglucosamine-
6-phosphate, adopts a chorismate lyase fold,
whereas the N-terminal domain contains a winged
helix–turn–helix DNA-binding domain. Isothermal
titration calorimetry and site-directed mutagenesis
revealed that the effector-binding site in YvoA coin-
cides with the active site of related chorismate lyase
from Escherichia coli. The characterization of the
DNA- and effector-binding properties of two
disulfide-bridged mutants that lock YvoA in two
distinct conformational states provides for the first
time detailed insight into the allosteric mechanism
through which effector binding modulates DNA
binding and, thereby regulates transcription in a
representative GntR/HutC family member. Central
to this allosteric coupling mechanism is a loop-
to-helix transition with the dipole of the newly
formed helix pointing toward the phosphate of the
effector. This transition goes in hand with the emer-
gence of internal symmetry in the effector-binding
domain and, in addition, leads to a 122  rotation of
the DNA-binding domains that is best described as
a jumping-jack-like motion.
INTRODUCTION
Bacteria are able to utilize a variety of diﬀerent carbohy-
drates. The corresponding metabolic genes are tightly
regulated by globally and speciﬁcally acting transcription
factors (1,2). Catabolic enzymes are in general only
synthesized when their substrate is present, and when oth-
erwise preferred carbon sources are absent. The underly-
ing regulatory mechanisms are referred to as induction,
carbon catabolite repression and inducer exclusion (2).
N-acetylglucosamine (GlcNAc) is a ubiquitous
monosaccharide derivative of glucose and an essential
molecule for all forms of life. GlcNAc is in addition a
preferred carbon source for many microorganisms as it
provides both carbon and nitrogen (3). YvoA is a bacterial
repressor from Bacillus subtilis implicated in the control of
the genes encoding GlcNAc degradative and biosynthetic
enzymes (2,4). This implication is based on in silico
analyses revealing that YvoA shares a sequence identity
of 38% with the well-studied DasR regulator of the
antibiotic-producing soil bacterium Streptomyces
coelicolor (3,5). DasR represents a master switch in a sig-
naling cascade from the nutrient GlcNAc to antibiotic
production. It does this by controlling genes of GlcNAc
and chitin metabolism as well as of transcription factors
for antibiotic synthesis (5).
YvoA and DasR probably recognize identical operator
sequences, the so-called dre (DasR responsive element) sites
(6). Conserved dre sites are found in the genome of
B. subtilis within the promoter regions of the
nagA-nagB-yvoA and of the nagP gene locus [(7);
Titgemeyer and Rigali, unpublished data]. nagP encodes
for a putative permease for GlcNAc while nagA and nagB
encode the metabolic enzymes N-acetylglucosamine-
6-phosphate deacetylase (NagA) and glucosamine-
6-phosphate deaminase (NagB), thus favoring the
production of fructose-6-phosphate that can then be
further metabolized through glycolysis (8,9). It has been
shown that transcription of nagA and nagB is induced by
GlcNAc (10). Hence, the genomic position and the
above-described analogy to DasR suggest that YvoA
controls nag gene expression in B. subtilis (7).
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bacterial transcriptional regulators. Members of this
family control various biological processes, including anti-
biotic production, sensing of nutritional status, growth,
proliferation and development (3,6). The GntR/HutC
proteins can be considered as molecular chimeras of two
domains. At their N-terminus they contain a winged
helix–turn–helix domain (wHTH) responsible for DNA
binding as a common feature of all members of the large
and disperse GntR superfamily of repressors (6,11,12).
The C-terminal part contains a chorismate lyase-type
UTRA domain, which in combination with the wHTH
domain is characteristic for the HutC subfamily of regu-
lators (13). Whereas chorismate lyase contains an active
site (14), HutC transcription regulators lack any enzy-
matic activity in the C-terminal domain. They contain a
ligand-binding pocket instead that allows HutC transcrip-
tion regulators to speciﬁcally recognize a variety of diﬀer-
ent eﬀector molecules. This domain encompasses an
allosteric mechanism that alters the aﬃnity of the
remote DNA-binding domains for DNA upon eﬀector
binding. Allosteric regulation is a hallmark of all bacterial
repressor proteins and enables them to function as molec-
ular switches that turn gene transcription on or oﬀ (15).
Several crystal structures of individual HutC eﬀector-
binding domains have been determined so far (16,17,
K.Tan, C.Hatzos, J.Abdullah and A.Joachimiak,
Midwest Center for Structural Genomics (MCSG),
unpublished data), and, recently, a single structure of an
entire HutC repressor has become available as part of the
MCSG structural genomics initiative. However, whereas
for numerous repressor families, the allosteric mechanism
by which eﬀector binding modulates DNA binding is
understood in atomic detail, as for instance the lactose
(18,19) and tetracycline repressor system (15,20), in case
of the HutC family, none of the structures solved so far
allowed for the identiﬁcation of either the eﬀector-binding
site or the allosteric mechanism by which these repressors
exert their function.
Here, we describe for the ﬁrst time the crystal structure
of full-length YvoA in what we consider to constitute
the induced conformation. The eﬀector-binding site
has been identiﬁed by site-directed mutagenesis, and the
characterization of disulﬁde-bridge-containing mutants
that lock YvoA in either the DNA-bound or the
eﬀector-bound induced conformation allows us to
propose a ‘jumping jack’ model for the allosteric induction
of YvoA.
MATERIALS AND METHODS
Protein cloning, mutagenesis, expression and puriﬁcation
YvoA (BSU35030, UniProtKB/TrEMBL entry O34817)
from B. subtilis and mutants thereof were expressed and
puriﬁed as described (21). Amino acid exchanges were
introduced by site-directed mutagenesis using the
QuikChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA 92037, USA). The following YvoA single
point mutants were generated: YvoA-I209E (using
primers I209Eforw: GAGCGCCTGTCCTATTAGAAA
AACGAACAACATATC, I209Erev: GATATGTT
GTTCGTTTTTCTAATAGGACAGGCGCTC), I209L
(I209Lforw: CGCCTGTCCTATTACTTAAACGAACA
ACATATC, I209Lrev: GATATGTTGTTCGTTTAAGT
AATAGGACAGGCG), E222D (E222Dforw: GAACGG
AACTGCTTTTAACCATGCAAAATCCG, E222Drev:
CGGATTTTGCATGGTTAAAAGCAGTTCCGTTC),
A224R (A224Rforw: CGGAACTGCTTTTGAGCATCG
TAAATCCGTATACAGAGGC, A224Rrev: GCCTCTG
TATACGGATTTACGATGCTCAAAAGCAGT
TCCG).
In addition, the following double-mutants were
generated: YvoA-K24C-G97C (using primers K24Cforw:
GCAATTAAAAACCCAAATTTGCAACGGAGAGCT
GCAGCCGG, K24Crev: CCGGCTGCAGCTCTCCGT
TGCAAATTTGGGTTTTTAATTGC; G97Cforw: GG
ATATGAAAAGCCGCTGCATGACACCGGGCAGC
AG, G97Crev: CTGCTGCCCGGTGTCATGCAG
CGGCTTTTCATATCC), and YvoA-E61C-L242C
(E61Cforw: GCGCTTTCTAATTTAGTTAATTGCGG
CTTGCTCTATCGCCTGAAAG, E61Crev: CTTTCAG
GCGATAGAGCAAGCCGCAATTAACTAAATTAG
AAAGCGC; L242Cforw: CATTTGTCCACTATAT
GGATCGTTGCTCATAAAAAAAGCCTCCAACCC,
L242Crev: GGGTTGGAGGCTTTTTTTATGAGCAAC
GATCCATATAGTGGACAAATG), performing two
consecutive rounds of site-directed mutagenesis for each
double mutant. After two-stage polymerase chain reaction
(PCR) (22), the parent plasmid strands were digested with
Dpn1 and the mutated strands chemically transformed
into competent Escherichia coli XL10 Gold cells
(Stratagene). Successful mutagenesis was conﬁrmed by
DNA sequence analysis.
For the production of selenomethionine substituted
YvoA (SeMet-YvoA), cells were grown at 37 Ct oa n
OD600 of 0.5 in minimal medium M9 supplemented with
0.8% (v/v) glycerol, 100mgml
 1 ampicillin, 10mgml
 1
kanamycin and a feedback inhibition mix containing
selenomethionine (23). After additional 15min of
shaking, the temperature was lowered to 20 C and
protein expression induced with 1mM IPTG. The puriﬁ-
cation protocol for SeMet-YvoA was the same as for the
wild-type and mutant proteins except that the aﬃnity
chromatography buﬀers additionally contained 5mM
dithiothreitol. Protein concentrations were determined
spectrophotometrically at 280nm with a calculated
molar extinction coeﬃcient of 16390M
 1cm
 1 and a
molecular weight of 27.8kDa. Typically, one litre of
bacterial culture yielded about 50mg of wild-type and
SeMet-YvoA protein and about 10–40mg of mutant
protein.
Limited proteolysis assay
YvoA protein was incubated at 25 C at a concentration of
0.35mgml
 1 (corresponding to 6mM YvoA dimer) for
time periods up to 3h with the nonspeciﬁc serine
protease subtilisin. The reaction buﬀer contained 20mM
Tris–HCl, pH 7.5, 0.15M NaCl and a ﬁnal amount of
0.014U subtilisin per milligram YvoA. Digestion was per-
formed in the presence or absence of 6mM dsDNA
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digestion was performed in the presence or absence of
1.5mM GlcNAc-6-P. After 0.5, 1, 5, 15, 30, 60 and
180min samples were withdrawn, and digestion was
stopped by adding equal volumes of sodium dodecyl
sulfate (SDS) sample buﬀer. Samples were immediately
boiled and examined by SDS gel electrophoresis.
Isothermal titration calorimetry
Calorimetric titrations of YvoA with GlcNAc-6-P were
performed with a VP-isothermal titration calorimetry
(ITC) microcalorimeter (MicroCal, Northampton, MA
01060, USA). Protein samples were extensively dialyzed
against ITC buﬀer containing 20mM sodium phosphate
(pH 7.5) and 150mM NaCl. All solutions were ﬁltered
using membrane ﬁlters (pore size 0.22mm) and degassed
for 30min by gently stirring under vacuum. The 1.35-ml
sample cell was ﬁlled with a 30mM solution of protein
(calculated for monomeric protein) and the 250ml injec-
tion syringe with a 10 or 20mM solution of the eﬀector.
Each titration typically consisted of an initial 2-ml injec-
tion followed by 25 consecutive 10-ml injections at 25 C.
Calorimetric titration of dsDNA with wild-type YvoA
was performed similarly. The 1.35-ml sample cell was
ﬁlled with a 12-mM solution of duplex DNA (ATTGGT
ATAGATCACTAG) (7) and the 250-ml injection syringe
with 125-mM wild-type YvoA (calculated for dimeric
protein). Data for the initial injection, which are aﬀected
by diﬀusion of the solution from and into the injection
syringe during the initial equilibration period, were dis-
carded. Binding isotherms were generated by plotting
the normalized reaction heats against the ratio of total
injectant to total protein per injection. Integrated heat
eﬀects, after correction for heats of dilution, were
analyzed by nonlinear regression with a one-site-binding
model using the standard Microcal Origin 7.0 software
package. Changes in free energy and entropy upon
binding were calculated from the equilibrium parameters
using the equation: G = RT lnK=H   T S ,
where R is the universal gas constant, T the temperature,
K the association constant, G  the change in Gibbs free
energy, H  the change in enthalpy and S  is the change
in entropy (24) under standard conditions.
Protein crystallization, data collection, structure
determination and reﬁnement
Selenomethionine-substituted YvoA was crystallized in
the absence of the eﬀector GlcNAc-6-P as described for
native YvoA (21). Two diﬀraction data sets [Se-multiple
wavelength anomalous dispersion (MAD)] were collected
from a single SeMet-YvoA crystal at 100K at synchrotron
beam line BL14.2 of Free University Berlin at BESSY
(Berlin, Germany) to maximum resolution of 2.4A ˚ .
Peak data were collected at a wavelength of 0.97965A ˚ in
0.5  oscillation steps covering a total rotation range of
125 . Inﬂection data were collected at a wavelength of
0.97979A ˚ , accordingly. Data were indexed and integrated
with XDS and scaled with XSCALE (25). The structure
was solved by the MAD method using program
AUTOSHARP (26). A polyalanine model generated
from the homolog PhnF C-terminal domain (PDB code:
2FA1) (16) was placed manually into the electron density
using the program COOT (27). The orientation of the
C-terminal domains was ﬁtted by rigid body reﬁnement
using REFMAC5 (28). The model was completed and
corrected manually using COOT and by alternating
with automated cycles of restrained atom position and
individual B-factor reﬁnement with REFMAC5 (28).
Noncrystallographic symmetry restraints were deﬁned
for two groups of residues (residues 1–77 and 78–242)
and applied to all 10 copies in the asymmetric unit
(chains A–J) during the reﬁnement. Sulfate ions and
water molecules were added in the ﬁnal stages of the
reﬁnement. During the ﬁnal stages of reﬁnement, group
atomic translation libration and skrew-rotation (TLS)
displacement parameters were reﬁned. The ten molecules
in the asymmetric unit were divided into 70TLS groups
(Supplementary Table S1) as suggested by the TLS motion
determination home page (30,31) (http://skuld.bmsc.
washington.edu/ tlsmd/). The resulting TLS tensors
were analyzed using TLSANL (32). A summary of the
crystallographic data collection and reﬁnement statistics
is presented in Table 1. All structure depictions were
generated using the program PYMOL (33). Coordinates
for the YvoA crystal structure have been deposited in the
Protein Data Bank (PDB, ID code 2WV0).
Homology modeling
YvoA in the DNA-bound conformation was modeled
using the ESyPred3D (34) web server 1.0 (http://www
.fundp.ac.be/sciences/biologie/urbm/bioinfo/esypred/).
Chain A from the crystal structure of the putative
transcriptional regulator YydK from B. subtilis (PDB
code: 3BWG) (K.Tan, M.Zhou, J.Abdullah and
A.Joachimiak, Midwest Center for Structural Genomics
(MCSG), unpublished data) was identiﬁed as the best
template for modeling. Superposition of the
DNA-binding domains of the model obtained above
onto the homologous DNA-binding domains from
FadR bound to DNA (PDB code: 1HW2) (35) was
calculated with the program LSQKAB (36).
RESULTS
Overall structure of YvoA
The crystal structure of YvoA was solved at 2.4A ˚ by
MAD using selenomethionine substituted YvoA
(Table 1). The crystals contain 10 molecules in the asym-
metric unit. Intriguingly, these form ﬁve crystallographic
dimers and are arranged along a 51 screw axis creating a
left-handed helix with a pitch of  160A ˚ and a  25A ˚
diameter pore at its centre (Supplementary Figure S1 A
and B). Of the 10 molecules (A–J), molecules A–F and I
are deﬁned best by their electron density, whereas mole-
cules G, H and J lack density for some segments and
display particularly high B-values in several surface
exposed regions.
The N-terminal part of the protein (residues 1–76)
contains a canonical wHTH DNA-binding domain with
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C-terminal domain via a 21 residue-long linker (residues
77–97; Figure 1A and B). The C-terminal eﬀector-binding
domain displays a chorismate lyase fold and contains a
six-stranded antiparallel b-sheet in its core (b4–9), which is
extended on one side by b-strand b10 from a second
monomer. The C-terminal domain displays a remarkable
topology as it contains a 2-fold internal repeat comprising
one-half of the central b-sheet and one-half of all ﬂanking
helices. The repeats are related by a pseudo 2-fold
symmetry axis that intersects with a bound sulfate ion
(sulfate-binding site 1, Figure 1C). This sulfate is located
on top of the central b-sheet ﬂanked by the helices a5 and
a9 and occurs in all YvoA monomers with the exception
of monomers H and J that display overall poorer density.
An additional sulfate-binding site (sulfate-binding site 2)
could be identiﬁed at the N-terminal end of helix a1
(Figure 1B). Again, this site is not occupied in all of the
10 molecules, and in total, the model contains 15 sulfates.
The N- to C-terminal inter-domain orientation is highly
conserved in all copies of YvoA in the crystal
(Supplementary Figure S1C). The average root-
mean-square deviation (r.m.s.d.) for the pairwise
superposition of the Ca atoms of all 10 monomers is
1.02A ˚ , suggesting that this orientation corresponds to a
low-energy conformation in YvoA.
The YvoA molecules dimerize via their eﬀector-binding
domains (Figure 1A) burying an average interface area of
1700A ˚ 2 per monomer. Dimerization is achieved via
hydrogen bonds formed between b-strands b7 and b100
and via salt bridges (between residues R241-E910,
D240-R1800, E171-R2410). Dimer formation can also be
monitored in solution, namely by gel ﬁltration (21) and
chemical cross-linking employing formaldehyde and
Table 1. Crystal parameters, X-ray data collection, phasing and reﬁnement statistics
Selenomethionine YvoA crystal
Se peak Se inﬂection Se native
Data collection
Beam line BESSY-MX, BL14.2
Wavelength (A ˚ ) 0.97965 0.97979 0.97965
Resolution (A ˚ ) 45.00–2.40 (2.50–2.40) 45.00–2.50 (2.60–2.50) 45.00–2.40 (2.50–2.40)
Space group C2
Cell parameters a=208.41, b=137.08, c=120.19A ˚ ,  =94.97 
No. of molecules in the ASU 10
I/ (I) 9.2 (1.9) 10.8 (1.7) 6.5 (2.3)
Rint
a (%) 4.4 (34.9) 4.1 (41.0) 8.4 (40.6)
Rmeas
b (%) 6.2 (49.3) 5.8 (57.9) 10.6 (51.1)
Rmrgd-F
b (%) 13.2 (61.4) 13.6 (75.6) 15.2 (53.1)
Unique reﬂections 249821 218213 130361
Redundancy 1.4 1.4 2.6
Completeness (%) 96.4 (96.6) 95.2 (92.2) 99.3 (100.0)
Wilson B-value (A ˚ 2) 63.4 67.3 55.4
Solvent content (%) 59.9
Phasing statistics (45.0–2.4A ˚ )
No. of sites 81 (found) out of 90 (possible)
Phasing power (ano, acentric) 1.696
RCullis
c (ano, acentric) 0.662
FOM (acentric/centric) 0.432/0.210
Reﬁnement statistics (100.0–2.4A ˚ )
Rwork/Rfree/Rtotal
d (%) 19.9/25.6/20.5
Number of non-hydrogen atoms 18689
Number of residues 2378
Number of solvent molecules 769
Additional molecules 15 SO4
2–
No. of TLS groups used in reﬁnement 70
Overall mean B-value (A ˚ 2) 64.5
Mean B-value of 10 protein chains (A ˚ 2) 65.4
Mean B-value of sulfates (A ˚ 2) 54.2
Mean B-value of water molecules (A ˚ 2) 54.2
R.m.s.d. from ideal geometry
Bond lengths (A ˚ ) 0.014
Bond angles ( ) 1.251
Ramachandran statistics
e (%) 92.5/7.4/0.1/0.0
aRint=hkl i |Ii(hkl)–<I(hkl)>|/hkl i Ii(hkl), where Ii(hkl) is the intensity measurement for reﬂection hkl, and <I(hkl)> is the mean intensity of
crystallographically replicants and symmetry-related reﬂections.
bRmeas is the multiplicity weighted merging R-factor, and Rmrgd-F is an indicator for the quality of the reduced data (47).
cRCullis=hkl || ano, obs|–|<ano, calc||/ hkl || ano, obs|, where ano, obs and ano, calc are the observed and calculated anomalous diﬀerences (36).
dRwork/Rfree/Rtotal=100 (hkl |Fo(hkl)-Fc(hkl)|/ hkl Fo(hkl)), where Fo and Fc are the observed and calculated structure factor amplitudes,
respectively. Rfree is calculated for 10% of randomly selected reﬂections excluded from reﬁnement.
eThe Ramachandran statistics were obtained with the program PROCHECK (48). Reported is the percentage of residues in the most favored,
additionally allowed, generally allowed and disallowed areas of the Ramachandran plot.
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dimerization mode is identical to that observed in crystal
structures of individual eﬀector-binding domains of
GntR/HutC family members such as in PhnF (PDB
code: 2FA1) (16), TreR (PDB code: 2OGG) (17) and
YurK from B. subtilis (PDB code: 2IKK) (K.Tan,
C.Hatzos, J.Abdullah and A.Joachimiak, Midwest
Center for Structural Genomics (MCSG), unpublished
data) as well as in full-length YydK (PDB code: 3BWG)
(K.Tan, M.Zhou, J.Abdullah and A.Joachimiak, Midwest
Center for Structural Genomics (MCSG), unpublished
data), which suggests that the observed dimerization
mode is characteristic for the GntR/HutC family of bac-
terial repressors.
The program DaliLite (http://ekhidna.biocenter.
helsinki.ﬁ/dali_server) (37) reported 27 diﬀerent entries
with Z-scores >10 as close structural neighbors of
YvoA. The nearest neighbor was identiﬁed as the
uncharacterized gene product SA0254 from
Staphylococcus aureus (PDB code: 2OOI) [R. Zhang,
E.Duggan, M.Gu, and A.Joachimiak, Midwest Center
for Structural Genomics (MCSG), unpublished data]
(r.m.s.d.=1.8A ˚ , sequence identity=22%) and the
second closest neighbor as YydK from B. subtilis (PDB
code: 3BWG) (PDB code: 2OOI) (r.m.s.d.=2.0A ˚ ,
sequence identity=27%). The E. coli enzyme chorismate
lyase (PDB code: 1G1B) (14) was identiﬁed at position 21
(r.m.s.d. of 3.0A ˚ and a global sequence identity of 14%;
for a superposition see Figure 1D). All entries corroborate
the observation that the occurrence of the fold of the
eﬀector-binding domain is restricted to either enzymes or
to the GntR/HutC family, of which YvoA appears to be a
representative member (13,14,38).
The YvoA eﬀector-binding site coincides with the
active site of chorismate lyase
HutC family members are expected to bind a variety of
diﬀerent eﬀector molecules but until now no structural
insight is available on any such complexes. In chorismate
lyase, eponymous for the fold of the eﬀector-binding
domain, the active site is located on top of the central
b-sheet near the geometric centre of the enzyme (13,14).
In YvoA, we observe a sulfate ion bound at an equivalent
position (Figure 1C). The sulfate is bound via the
N-termini of helices a5 and a9, by the guanidinium
groups of R133 and R135, by the hydroxyl groups of
T90 and S165, and by the backbone amides of F89,
S165, I166 and Y167 (Figure 2).
We hypothesized that this sulfate ion occupies the
position at which low-molecular-weight eﬀectors interact
with YvoA. As glucosamine-6-phosphate (GlcN-6-P) has
been identiﬁed as the eﬀector of the YvoA homolog DasR
(3), and because both proteins are implicated in the regu-
lation of the GlcNAc metabolism, we reasoned that
GlcN-6-P might also be the eﬀector of YvoA. Therefore,
we probed wild-type YvoA for binding GlcN-6-P as well
as the related molecule N-acetylglucosamine-6-phosphate
(GlcNAc-6-P). Only for the latter, we were able to obtain
interpretable ITC-binding curves yielding a dissociation
constant of 1mM (Kd) (Table 2, Figure 2A). This
Figure 1. Key structural features of YvoA from Bacillus subtilis. (A) Crystal structure of the YvoA homodimer (orange/cyan) at 2.4-A ˚ resolution
with bound sulfate ions. Residues/positions susceptible to proteolytic cleavage are marked in red and purple. (B) Topology plot of the YvoA
monomer. Circle and asterisk mark the sulfate-binding sites 1 and 2, respectively. (C) Ribbon representation of the eﬀector-binding domain high-
lighting the internal 2-fold rotational symmetry of the fold. The 2-fold axis passes through the sulfate ion that is hold in place by helices a5 and a9.
(D) Stereo view of the superimposition of the eﬀector-binding domain of YvoA (orange) and chorismate lyase from E. coli (in green, PDB
code: 1G1B) (14).
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indicate that yet unknown YvoA eﬀectors with higher
aﬃnities exist. On the other hand, when considering that
the intracellular concentrations of GlcNAc-6-P lie in the
range of 1–10mM under GlcNAc catabolizing conditions
(Fritz Titgemeyer, personal communication), a high occu-
pancy of the eﬀector-binding site can be achieved despite
the low overall aﬃnity of GlcNAc-6-P.
To unambiguously identify the GlcNAc-6-P-binding
site, we generated several point mutants and tested their
ability to bind GlcNAc-6-P (Table 2). Proper folding of
each mutant was conﬁrmed by circular dichroism (CD)
spectroscopy (Supplementary Figure S2 A and B).
Introducing small changes in the side-chains near the
bound sulfate ion caused no or little eﬀects on
GlcNAc-6-P binding (mutants E222D and I209L,
Supplementary Figure S3 A and B). Introduction of
bulky and charged side-chains abolished GlcNAc-6-P
binding completely (mutants I209E and A224R,
Figure 2B and C).
An additional clue that the sulfate and eﬀector-binding
sites coincide can be derived from residual electron density
in the initial MAD-phased experimental density map near
monomer B that cannot be ascribed to the protein
(Figure 2D). Guided by this density, GlcNAc-6-P could
be docked into the binding site without any steric clashes.
In addition to the interactions of the phosphoryl group of
GlcNAc-6-P, which are identical to those of the sulfate
molecule, GlcNAc-6-P is able to establish numerous
hydrogen bonds, mainly via side-chain atoms, together
with a few hydrophobic contacts such as that found
between Y167 and C6 of the glucose moiety (Figure 2D
and E). Close inspection of the proposed binding mode
also reveals striking similarity to the binding mode of
Figure 2. GlcNAc-6-P eﬀector binding to YvoA. (A–C) Binding isotherms of YvoA and YvoA mutants (0.9mgml
 1) titrated with 10mM
GlcNAc-6-P. (A)Wild-type YvoA, (B) YvoA-I209E and (C) YvoA-A224R. (D) Stereo view showing the proposed eﬀector-binding site of YvoA.
GlcNAc-6-P in b-conﬁguration can be docked into weak non-protein electron density present in the initial MAD-phased experimental electron
density map near monomer B (in blue). (E) Schematic representations of the interactions between GlcNAc-6-P and side-chains from the
eﬀector-binding site of YvoA (chain B). GlcNAc-6-P is not part of the deposited reﬁned crystal structure and is therefore colored transparently.
The position of the sulfate coincides with that of the phosphate group of GlcNAc-6-P.
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(PDB code: 2DKC; (39); Supplementary Figure S4),
despite the fact that the folds of the two proteins are
unrelated. Any trial calculations aiming at including
GlcNAc-6-P into the crystallographic reﬁnement
remained unsuccessful and no unambiguous electron
density was obtained for the glucose moiety of the
ligand after reﬁnement. Therefore, only the bound
sulfate molecule was included in the ﬁnal structure. Any
attempts to obtain a GlcNAc-6-P-bound structure of
YvoA failed so far.
Interestingly, the crystal structures of the related HutC
members trehalose repressor TreR of B. subtilis (PDB
code: 2OGG) (17) and YurK from B. subtilis (PDB
code: 2IKK) contain also a sulfate ion at the same
position. Even the corresponding residues R128 and
R130 are conserved in TreR and YurK (R130 is
replaced by a histidine in YurK). In TreR it has been
proposed that the sulfate mimics the phosphoryl group
of the eﬀector trehalose-6-phosphate (17). From a struc-
tural point of view, it is not uncommon that an anion
binds to the N-termini of two a-helices as it is well
known that a-helices are able to favor the binding of neg-
atively charged ligands at this position either via the helix
dipole or/and via direct hydrogen-bond donation (40–42).
It is quite likely that the high sulfate concentration used
during crystallization (21) led to the occupancy of the
GlcNAc-6-P-binding site by sulfate ions. Moreover,
since eﬀector binding leads to the induction of YvoA,
the possibility must be considered that the observed struc-
ture of YvoA represents the induced conformation with
impaired DNA operator-binding capability.
YvoA binds DNA in a two-step mechanism
YvoA has been proposed to recognize the natural
occurring operator sequence ATTGGTATAGATCACT
AG from B. subtilis (7), which is highly similar to the
common dre sites found in S coelicolor (43). We
investigated DNA binding of YvoA using this
double-stranded DNA (dsDNA) and analytical gel ﬁltra-
tion chromatography (Figure 3A). When dimeric
wild-type YvoA is added in equimolar amounts to
dsDNA, the YvoA–DNA complex elutes as a
DNA-bound YvoA dimer. In contrast, when YvoA is
added in 3.5-fold molar excess over dsDNA, a tetrameric
state is observed (two YvoA dimers bind to one dsDNA,
Figure 3A). The oligomeric states were determined by
linear regression employing a calibration curve. In order
to further characterize DNA binding, ITC was conducted
with the same dsDNA by titrating YvoA to DNA
(Supplementary Figure S5A, Table 2). The binding
revealed an apparent Kd of 131.2nM. Inversely, when
dsDNA was titrated to YvoA, a biphasic isotherm was
observed with two diﬀerent Kd values revealing negative
co-operativity (Supplementary Figure S5B, Table 2). This
suggests a two-step-binding mechanism for YvoA. In the
ﬁrst step and in the presence of excessive YvoA, two
YvoA dimers bind to one molecule of dsDNA via only
one of the two DNA-binding domains present in each
dimer. In the subsequent step, and upon increasing the
DNA concentrations, one YvoA dimer dissociates from
the complex and the remaining dimer now contacts the
dsDNA with both binding domains. In case when
dsDNA is present in excess, the complex of a YvoA
dimer bound to dsDNA is formed from the onset.
It is not possible to explain the formation of a 1:1
complex between dimeric YvoA and dsDNA on the
basis of the YvoA crystal structure since in the structure
the DNA-binding domains are splayed apart so that they
cannot contact both half-sites of a single operator site
simultaneously. To obtain a structural model of YvoA
that would allow for the formation of such a complex,
we considered the structure of the homolog transcriptional
regulator YydK from B. subtilis (PDB code: 3BWG).
YydK exhibits 27% sequence identity to YvoA, and its
DNA-binding domains are oriented diﬀerently than in
YvoA. They are paired together at the dimer interface
and in this conformation the DNA recognition helices
a3 and a30 appear at the correct distance to bind into
neighboring major grooves of dsDNA. This possibility is
supported by a comparison of YydK with the crystal
structure showing how the DNA-binding domains
Table 2. Eﬀector and DNA-binding aﬃnities determined by ITC
Kd (M) n H a G a TDS a
GlcNAc-6-P was titrated to
Wild-type YvoA 1.0 10
 3 1
b –18.9 –17.1 –1.8
YvoA-E222D 1.1 10
 3 1
b –21.2 –17.0 –4.2
YvoA-I209L 3.3 10
 3 1
b –35.9 –14.2 –21.7
YvoA-I209E No binding observed – – – –
YvoA-A224R No binding observed – – – –
YvoA-E61C-L242C No binding observed – – – –
YvoA-K24C-G97C 1.8 10
 3 1
b –16.8 –15.6 –1.2
Wild-type YvoA was titrated to
dsDNA (18mer) 131.2 10
 9 1
c 26.9 –39.3 66.2
dsDNA was titrated to
Wild-type YvoA 2.9 10
 9 (Kd1) n1 0.47
c H 
1 –26.4 G 
1 –48.7 TDS 
1 22.3
0.5 10
 6 (Kd2) n2 0.44
c H 
2 70.0 G 
2 –36.1 TDS 
2 106.1
aUnits are in kJmol
 1.
bThis stoichiometry factor refers to an YvoA monomer.
cThis stoichiometry factor refers to dimeric YvoA.
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The DNA-binding domain dimer of FadR can be
superimposed with the corresponding domains of YydK
with an r.m.s.d. of 5.3A ˚ for all Ca atoms. The deviations
between single DNA-binding domains are signiﬁcantly
lower (1.6A ˚ ). Although a Ca r.m.s.d. of 5.3A ˚ suggests
notable diﬀerences in the dimer assembly, the overall
orientation of the DNA-binding domains is very similar
in both proteins. Any diﬀerences could originate
either from the fact that YydK was crystallized in the
absence of DNA or from the observation that the two
operator half sites are separated by a diﬀerent number
of nucleotides in the operators of YydK/YvoA and
FadR (Table 3). Consequently, a slightly diﬀerent posi-
tioning of the DNA-binding domains could be neces-
sary for optimal DNA-binding in these repressors. The
overall similarity, however, allows for the construc-
tion of a composite model for the DNA-bound
conformation of YvoA in which the two DNA-binding
domains display a similar orientation than in YydK and
FadR (Figure 3B).
Analysis of the composite model and of the protein
sequences shows that the wHTH domain in YvoA is
even more similar to FadR (35% sequence identity) than
to YydK (30% identity; Figure 3C). Two of three residues
that are known to speciﬁcally recognize the operator
sequence in FadR (R35, R45 and H65; FadR numbering)
(35,44) are conserved in YvoA (Figure 3C). Moreover, key
residues which are suggested to form salt bridge interac-
tions with phosphate groups or to stabilize the positions of
the aforementioned arginines in FadR (35) are conserved
in YvoA, namely residues E37, S47, T50, R52 and G69
(YvoA numbering, Figure 3C). At the same time, the
operator sequence of FadR shows signiﬁcant similarity
to that of YvoA (Table 3) (7,35). In summary, the
sequence similarities between FadR and YvoA suggest
Figure 3. DNA-binding properties of YvoA. (A) Gel ﬁltration of YvoA (solid line), upon addition of equimolar dsDNA (dashed line), and with
YvoA in excess over dsDNA (dotted line) demonstrating clear shifts of the elution peaks as a function of the protein:DNA ratio. (B) Ribbon
representation of a DNA-bound YvoA model. The composite model was generated by modeling YvoA according to the conformation observed in
YydK (PDB code: 3BWG) and superimposed on the DNA-binding heads of the DNA-bound wHTH domains of FadR (PDB code: 1HW2) (35). (C)
Sequence alignments of the DNA-binding domains of YvoA from B. subtilis, FadR from E. coli, and YydK from B. subtilis. The secondary structure
elements, indicated by helices and arrows, refer to YvoA. Residues conserved between YvoA and FadR (and partially YydK) are highlighted by blue
shaded boxes. Residues conserved only between YvoA and YydK are indicated by cyan shaded boxes. Residues implicated in DNA binding in FadR
(35) are highlighted by red boxes.
2492 Nucleic Acids Research, 2010, Vol.38, No. 7that the DNA-binding mode of YvoA resembles that of
FadR despite the fact that FadR is a member of a diﬀerent
subfamily of GntRs. Therefore, the FadR/YydK-derived
composite model represents a likely conformation of a 1:1
complex between dimeric YvoA and dsDNA.
DNA and eﬀector binding require two distinct
conformations
The above considerations suggest that YvoA adopts two
distinct conformations when bound either to a small
molecule eﬀector or to DNA. To investigate the binding
properties of these two conformations, we designed
two disulﬁde-bridged mutants that lock YvoA either in
the modeled DNA-bound conformation (YvoA-E61C-
L242C) or in the conformation that we observe in the
crystal structure (resembling the eﬀector-bound induced
conformation, YvoA-K24C-G97C) (Figure 4A and B).
The successful production and characterization of the
disulﬁde-bridged mutant YvoA-E61C-L242C (Figure 4A)
provides strong evidence that YvoA is able to adopt the
inferred DNA-binding conformation. The successful for-
mation of the intermolecular disulﬁde bridges could be
Figure 4. Models of disulﬁde-bridged YvoA mutants and their DNA-binding properties. (A) Model of the homodimeric cystein mutant
YvoA-E61C-L242C viewed from two diﬀerent angles. This model is supposed to represent the DNA-bound conformation leading to repression
of YvoA-controlled genes. The inset shows the region around the intermolecular disulﬁde bridge between C61 and C2420.( B) Model of the
homodimeric cystein mutant YvoA-K24C-G97C resembling the induced conformation. The inset shows the region around the intramolecular
disulﬁde bridge between C24 and C97. (C) Left: gel ﬁltration of free wild-type YvoA (black), YvoA-E61C-L242C (blue), and YvoA-K24C-G97C
(red) reveals only small diﬀerences in the elution proﬁle. Right: gel ﬁltration of YvoA variants in the presence of dsDNA (18mer) shows major peak
shifts. The black line represents wild-type YvoA in the presence of equimolar dsDNA. The blue line shows YvoA-E61C-L242C in excess over
dsDNA. The red line represents YvoA-K24C-G97C in the presence of equimolar dsDNA.
Table 3. Comparison of DNA operator sequences of YvoA from B.
subtilis and FadR from E. coli
Source DNA sequence
YvoA operator from B. subtilis (7) TGGTATAGATCA
YvoA/DasR consensus dre, palindrome (43) TGGTCTAGACCA
FadR operator from E. coli, palindrome (35) TGGTCC-GACCA
FadR operator consensus, palindrome (35) TGGTNN-NACCA
Conserved bases in the YvoA/FadR operator sequences are underlined.
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electrophoresis (PAGE) (data not shown). Isothermal
titration of YvoA-E61C-L242C demonstrated its inability
to bind GlcNAc-6-P, as anticipated for a non-inducible
locked mutant (Table 2, Supplementary Figure S3C).
CD spectroscopy and gel ﬁltration experiments showed
that the impaired eﬀector binding is not due to a loss of
structural integrity (Figure 4C, Supplementary Figure S2).
According to our model, this mutant is expected to bind
DNA exclusively in a one-to-one complex (one YvoA
dimer bound to dsDNA). Indeed, even with a 3.5-fold
molar excess of YvoA-E61C-L242C over dsDNA, the
protein–DNA complex eluted in a gel ﬁltration experi-
ment as expected for a one-to-one complex in support of
the validity of the DNA-bound YvoA model (Figure 4C).
Gel ﬁltration chromatography was also performed with
a second YvoA mutant locked in the disulﬁde-bridged
induced conformation (Figure 4B). Again, CD spectros-
copy and gel ﬁltration experiments conﬁrmed the struc-
tural integrity of this mutant (Figure 4C, Supplementary
Figure S2). As anticipated, the mutant YvoA-K24C-G97C
was still able to bind GlcNAc-6-P (Table 2,
Supplementary Figure S3D). The slightly reduced
binding eﬃciency possibly stems from a reduced accessi-
bility of the eﬀector-binding site in this mutant.
Unexpectedly, the mutant YvoA-K24C-G97C was also
able to bind DNA (Figure 4C). However, in contrast to
wild-type YvoA, the YvoA-K24C-G97C–DNA complex
did not elute as a complex of dimeric YvoA plus
dsDNA but in the void volume of the column instead,
irrespective of whether YvoA was present in excess over
DNA (data not shown) or in equimolar concentration
(Figure 4C). In this mutant, in which the DNA-binding
domains are splayed apart, YvoA appears to bind to two
diﬀerent dsDNA molecules and at the same time the two
operator half-sites interact with two diﬀerent YvoA
dimers. As a result, a linear polymer is formed
composed of alternating YvoA dimers and dsDNA
building blocks. Obviously, in this disulﬁde-bridged con-
formation, no complex can be formed in which one YvoA
dimer binds to a single operator dsDNA.
Further indications that YvoA adopts distinct confor-
mations upon binding to either small molecule eﬀectors or
to DNA are obtained with limited proteolysis experi-
ments. When exposed to small amounts of the unspeciﬁc
serine protease subtilisin, diﬀerent proteolytic products
are observed depending on whether no ligand, dsDNA
or GlcNAc-6-P is present (Figure 5, Supplementary
Figure S6). In the absence of both dsDNA and
GlcNAc-6-P, three stable fragments can be observed in
SDS gels. These start with amino acid residues K5, R96
and L86 (residues C-terminal to the scissile bond; marked
‘double dagger’, ‘dagger’ and ‘asterisk’ in Figure 5). The
latter two lie in the interdomain region between the
DNA-binding domain and the eﬀector-binding domain
(a4-L86-a5-R96-b4). In the presence of dsDNA, the frag-
ments that start at L86 and R96 re-occur with R96
becoming the most abundant. In contrast, when
GlcNAc-6-P is present, a fourth band starting with
residue R70 emerges. R70 is located in the loop connecting
strand b2t ob3 within the DNA-binding domain of YvoA
(marked by ‘section’ in Figure 5, see also Figure 1A).
Two plausible explanations exist for the emergence of
the R70 fragment upon GlcNAc-6-P addition. It is
possible that R70 is protected in the ligand-free and in
the DNA-bound structure so that no cleavage can occur
at this position. Likewise, cleavage at R70 could occur
rapidly in all samples but subsequent cleavage at
residues R96 and L89 could be slowed down in the
presence of the inducer so that the R70 fragment
emerges as a stable fragment. The second explanation
seems likely since the accessibility of residue R70 should
vary considerably in the ligand-free and DNA-bound
structure without this being reﬂected in the observed frag-
mentation pattern. Moreover, we observe that in the
DNA-bound model as well as in the YydK template,
from which the model was derived, the interdomain
segment containing residues R96 and L89 is disordered
and might therefore be preferentially cleaved. In
contrast, in the sulfate-bound crystal structure, which we
propose to mimic the GlcNAc-6-P-bound structure, the
region 77–97 is ordered in agreement with a reduced sus-
ceptibility to proteolytic cleavage.
DISCUSSION
Allosteric mechanism of induction
Bacterial repressors function as molecular switches and
binding of low-molecular-weight eﬀectors modulate their
ability to interact with operator DNA. Following the
characterization of two distinct conformational states in
YvoA that we propose to describe either eﬀector- or
operator-bound YvoA, the question arises: what is the
nature of the mechanism that triggers the transition
between both conformations? Comparison of the
DNA-bound YvoA model and the crystal structure
Figure 5. Limited proteolysis assay of YvoA. YvoA (0.35mgml
 1, i.e.
6-mM dimer) was incubated for 180min with 0.014Umg
 1 subtilisin in
the presence or absence of dsDNA and/or GlcNAc-6-P. ‘Double
dagger’, ‘dagger’, ‘asterisk’ and ‘section’ mark cleavage products
starting with the N-terminal residues K5, R96, L86 and R70, respec-
tively. Molecular mass estimates suggest that the fragments R96, L86
and R70 result from a single cleavage event. This is not the case for the
K5 fragment, which is further truncated toward the C-terminus. For
complete time courses see Supplementary Figure S6.
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DNA-binding domain to the eﬀector-binding domain
(residues 77–97). In the DNA-bound model, these
residues form a partially disordered loop, as apparent
from the observed susceptibility of the residues within
this loop for proteolysis and the observation that the
corresponding YydK residues 82–89 are not visible
in the electron density of YydK (PDB code: 3BWG)
(Figure 6A). Upon eﬀector binding, these residues
undergo a conformational transition that can be described
as a loop-to-helix transition. In particular, residues 80–84
and 89–95 switch their conformation and form helices a4
and a5 in the induced-like YvoA crystal structure.
We propose that the negatively charged phosphate
group of GlcNAc-6-P (or the sulfate molecule in the
crystal structure) triggers this transition. Binding of
GlcNAc-6-P to the N-terminus of helix a9 might not
just stabilize the dipole moment of this helix but
might at the same time induce the formation of helix a5.
Upon helix a5 formation, the phosphate becomes sand-
wiched between the N-termini of both helices with both
helix dipoles pointing toward the phosphate (Figures 2B
and 6B). Helix a5 formation might concomitantly induce
cooperative folding of neighboring helix a4 as a key step
in the propagation of the allosteric signal toward the
DNA-binding domains. An interesting feature of this
Figure 6. Induction mechanism of YvoA. (A) Stereo representation of the allosteric rearrangement in YvoA upon eﬀector binding. The model in the
DNA-bound conformation is shown in grey, the crystal structure of induced YvoA in orange. The interdomain loop in the DNA-bound model is
highlighted in blue. Upon eﬀector binding, this loop switches conformations and folds into helices a4 and a5 (colored in red). As a consequence, the
DNA-binding domain rotates as a rigid body by 122  around the indicated axis. (B) Magniﬁed stereo view of helices a4 and a5 in induced YvoA.
The sA-weighted 2Fo–Fc electron density map shows well-deﬁned, continuous density for the interdomain linker in YvoA. (C) Allosteric mechanism
of YvoA induction. In the DNA-binding conformation (in gray), homodimeric YvoA binds DNA with its DNA recognition helices paired together
at the dimer interface and binding into successive major grooves. In doing so, YvoA is able to block transcription of any downstream genes. Upon
eﬀector (GlcNAc-6-P) binding, the interdomain linker region undergoes a loop-to-helix transition forcing the DNA-binding domains apart in a
‘jumping jack’-like motion (orange). YvoA is then not able any more to bind to the same dsDNA duplex with both DNA-binding domains
simultaneously, causing de-repression of YvoA-controlled genes.
Nucleic Acids Research,2010, Vol.38, No. 7 2495mechanism is that formation of helices a4 and a5 gener-
ates internal symmetry within the eﬀector-binding domain
(Figure 1B and C) with the 2-fold symmetry axis intersect-
ing with the phosphate/sulfate group bound in the
eﬀector-bound conformation. Concurrently with this
gain in symmetry, the DNA-binding domains are
reoriented and forced apart in a ‘jumping jack’-like
motion (Figure 6C). The observation that many of the
HutC/GntR family members bind phosphate-containing
eﬀector molecules suggests that this allosteric induction
mechanism may be common to the members of the
HutC/GntR family.
Regulatory implications for gene transcription in vivo
In analogy to other repressors, such as the tetracycline and
lac repressor (15,18), we expected the eﬀector-bound
induced conformation to be incompatible with DNA
binding. However, this is not the case. This discovery is
remarkable when viewed in the context of dual transcrip-
tion regulators that act as both repressors and activators.
This appears to hold true for several regulators implicated
in both the transcription of anabolic and catabolic genes
such as the E. coli FadR regulator and B. subtilis arginine
repressor/activator AhrC (35,45,46). When FadR binds
downstream of the RNA polymerase-binding site within
the promoter, it blocks the polymerase and acts as a
repressor (35). Conversely, when bound upstream, it
promotes binding of the RNA polymerase (35) and acts
as an activator. In case of YvoA, one could speculate that
yet another mechanism might apply. In addition to
blocking transcription through binding to dre-operator
sites in the above characterized DNA-bound conforma-
tion, it is conceivable that YvoA, through binding to
two diﬀerent dre sites in the splayed induced conforma-
tion, brings two operons together, like for example the
nagAB and the nagP operon located in diﬀerent regions
of the genome, possibly facilitating concomitant transcrip-
tion of these genes. Thus, YvoA could switch between
repressor and activator and thereby rapidly respond to
cellular requirements. A clearer picture, however, will
have to await additional experimental evidence.
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